Scancell hails "compelling" results from clinical trial
The study showed the response to SCIB1 was “significantly stronger” at higher doses, while the drug worked better for those patients who already had the tumour removed before treatment.
Company
Scancell Holdings PLC
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
329 stories · page 14 of 17
Proactive news round-up: Eurasia Mining, Scancell, Metal Tiger ...
A glance at today's Proactive small -cap stories from the newswire
Risers & Fallers: Eurasia Mining , Richoux , Papua Mining...
Main share price risers and fallers in London at 4pm
Investments and investor services
FTSE100 shares flirt with record high close
FTSE 100 shares came within a handful of points of marking a fresh record high close on Monday, but for all the gains of mining stocks the ticker just could not muster the umph to triumph
Proactive news highlights: Braveheart, Harvest Minerals, Horizonte, Kibo Mining, Rosslyn Data...
Daily summary of some of the top Proactive news headlines.
Proactive news highlights: Base Resources, Galileo Resources, ImmuPharma, Sound Energy and more...
Daily round up of the day's news headlines from Proactive Investors.
Proactive news highlights: Alecto Minerals, Image Scan, LGO Energy, MySQUAR and more...
LGO Energy has successfully recompleted the GY-277 well, Image Scan is on track to break even, and Avation has purchased and delivered another brand new Airbus.
Scancell adds heavy hitter to board
Dr Alan Lewis brings "a wealth of industry experience, both commercially and financially," said Scancell chairman Dr John Chiplin
Proactive news round-up: Fastjet, Metminco, Breedon Aggregates...
A round-up of small cap newswire storiest today on Proactive
Scancell turns to Belgian group to replenish vaccine stocks
Scancell wants the drugs for a US clinical study of SCIB1 in combination with a checkpoint inhibitor
Scancell extends commercial licence with Ichor
Scancell will continue to use Ichor’s electroporation delivery system in conjunction with its flagship skin cancer vaccine.
Proactive news highlights: African Potash, Berkeley Energia, KEFI Minerals, Motif Bio and more...
Berkeley Energia suspends shares, KEFI Minerals shuffles its board, and Scancell's technology is highlighted by the scientific community.
Scancell’s cancer vaccine programme boosted by scientific review
“We believe this platform has the potential to develop a new class of immuno-oncology therapeutics and look forward to progressing our first vaccine into the clinic as soon as possible."
London stocks fall as Brexit woes continue to weigh
London’s FTSE 100 closed down on Wednesday in a repeat of the previous session’s gyrations over the ongoing Brexit vote shock
Archive
Proactive news highlights: Featuring Hummingbird Resources, Shanta Gold and Breedon Aggregates
Hummingbird begins detailed engineered at Yanfolila; Shanta Gold exploration yields some encouraging results; Breedon Aggregates proposes a name change; and more…
Scancell ever closer to tackling most deadly form of cancer
With cases of skin cancer on the rise, Scancell's immunotherapy study data has come at the right time, but is it enough to offset the insecurity in the sector?
Investments and investor services
FTSE 100 Index falls as pound plunges to new low
The FTSE 100 Index reversed modest gains to stand 103.29 points adrift at 6442.08
Risers and fallers, including Kolar Gold, Shanta, Melrose and Barratt Developments
A first look at some of the notable market movers on Wednesday